Cancer Clinic

Treatment discontinuation after complete response to BRAF/MEK inhibition in metastatic melanoma: long-term clinical outcomes from a single institution

The optimal duration of BRAF/MEK inhibitor therapy in patients with metastatic melanoma who achieve complete response remains uncertain. Although targeted therapy is commonly continued until disease progression or unacceptable toxicity, prolonged treatment may be associated with...

Exploring Patient Needs and Respective Contributing Factors Regarding Hospital and Community Pharmacists for Outpatients with Cancer

Improving the quality and safety of outpatient chemotherapy requires effective information sharing between hospitals and community pharmacies. However, achieving truly patient-centered care necessitates pharmacists to go beyond information exchange and develop a deeper understand...

Outdoor workers and skin cancer in Australia: are our workplace policies sufficient?

Australia has one of the highest rates of skin cancer globally, and outdoor workers represent a key high-risk population due to prolonged occupational sun exposure. Despite a robust legislative framework mandating comprehensive workplace sun protection, evidence indicates subopti...